Quantum量子訊息有限公司
← 最新全球產業報告

Nucleic Acid Sample Preparation Market

研究執行與發布:TechSci Research · 發布日期 2026-05-01 · 185 頁
由量子訊息有限公司(Quantum Information)在台灣代理銷售與提供授權諮詢。

出版商 TechSci Research產業別 Healthcare & Life Sciences出版日期 2026-05-01頁數 185報告編號 TSR-14942

授權報價

Single User License$4,500 USD
Multiple User License$5,500 USD
Custom Research License$8,000 USD
洽詢購買 申請 Sample
完整報告名稱與涵蓋範圍
Nucleic Acid Sample Preparation Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product (Consumables, Systems, Accessories & Components), By Technology (Spin-Column Based Technology, Magnetic-Bead Based Technology, Others), By Therapeutic Area (Oncology, Infectious Disease, Human Genetics/Population Genetics, Others), By Application (Genomics, Proteomics, Others), By End Users (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Other), By Region & Competition, 2021-2031F

報告摘要

Market Overview The Global Nucleic Acid Sample Preparation Market is projected to expand from USD 2.99 Billion in 2025 to USD 4.41 Billion by 2031, achieving a 6.69% Compound Annual Growth Rate. This market centers on the extraction, isolation, and purification of DNA and RNA from biological samples to yield high-quality material for critical downstream analytical uses like amplification and sequencing. Market Driver Key drivers for this expansion include the rising incidence of infectious diseases and cancer, demanding extensive molecular diagnostic testing, and the burgeoning field of precision medicine, which requires reliable, high-purity nucleic acid extraction for accurate genomic profiling. The substantial demand for sample processing within biopharmaceutical research is further evidenced by over 8,000 medicines in clinical development in 2024. Furthermore, the increasing adoption of Next-Generation Sequencing and molecular diagnostics is fueling market growth by imposing stringent quality standards on extracted nucleic acids for generating reliable data in areas such as liquid biopsy. Market Challenge Despite these robust growth factors, the Global Nucleic Acid Sample Preparation Market faces a significant impediment due to the high capital investment required for automated nucleic acid extraction platforms. This substantial initial expenditure often proves prohibitive for smaller laboratories and diagnostic centers, which are then compelled to rely on less efficient, labor-intensive manual extraction methods. Such budgetary constraints directly limit market penetration for advanced technologies and concentrate their adoption within larger, well-funded reference laboratories. Evidence from the American Hospital Association in 2025 indicates that 94% of healthcare administrators anticipated delaying equipment upgrades due to persistent financial strain, underscoring how this widespread deferral of capital projects impedes the market by extending the lifecycle of legacy equipment rather than fostering investment in modern automated workflows essential for scaling genomic profiling and diagnostic testing. Market Trends Complementing this growth, the market is experiencing an increase in the adoption of automated liquid handling workstations, which enhance reproducibility and operational efficiency by standardizing nucleic acid yields and reducing manual effort, alongside the development of high-precision kits for single-cell genomics, critical for isolating genetic material from individual cells for advanced applications in immunology and spatial biology. Key Market Players * BGI Group * F. Hoffmann-La Roche Ltd * Danaher Corporation * Eppendorf SE * BIONEER CORPORATION * Endress+Hauser Group Services AG * Merck KGaA * Norgen Biotek Corp. * Aurora Biomed Inc. * Agilent Technologies, Inc. Report Scope In this report, the Global Nucleic Acid Sample Preparation Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below: # Nucleic Acid Sample Preparation Market, By Product * Consumables * Systems * Accessories & Components # Nucleic Acid Sample Preparation Market, By Technology * Spin-Column Based Technology * Magnetic-Bead Based Technology * Others # Nucleic Acid Sample Preparation Market, By Therapeutic Area * Oncology * Infectious Disease * Human Genetics/Population Genetics * Others # Nucleic Acid Sample Preparation Market, By Application * Genomics * Proteomics * Others # Nucleic Acid Sample Preparation Market, By End Users * Academic and Research Institutions * Pharmaceutical and Biotechnology Companies * Clinical and Diagnostic Laboratories * Other # Nucleic Acid Sample Preparation Market, By Region * North America United States Canada Mexico * Europe France United Kingdom Italy Germany Spain * Asia Pacific China India Japan Australia South Korea * South America Brazil Argentina Colombia * Middle East & Africa South Africa Saudi Arabia UAE Competitive Landscape Company Profiles: Detailed analysis of the major companies present in the Global Nucleic Acid Sample Preparation Market. Available Customizations: Global Nucleic Acid Sample Preparation Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: Company Information * Detailed analysis and profiling of additional market players (up to five).
目錄 Table of Contents
1. Product Overview 1.1. Market Definition 1.2. Scope of the Market 1.2.1. Markets Covered 1.2.2. Years Considered for Study 1.2.3. Key Market Segmentations 2. Research Methodology 2.1. Objective of the Study 2.2. Baseline Methodology 2.3. Key Industry Partners 2.4. Major Association and Secondary Sources 2.5. Forecasting Methodology 2.6. Data Triangulation & Validation 2.7. Assumptions and Limitations 3. Executive Summary 3.1. Overview of the Market 3.2. Overview of Key Market Segmentations 3.3. Overview of Key Market Players 3.4. Overview of Key Regions/Countries 3.5. Overview of Market Drivers, Challenges, Trends 4. Voice of Customer 5. Global Nucleic Acid Sample Preparation Market Outlook 5.1. Market Size & Forecast 5.1.1. By Value 5.2. Market Share & Forecast 5.2.1. By Product (Consumables, Systems, Accessories & Components) 5.2.2. By Technology (Spin-Column Based Technology, Magnetic-Bead Based Technology, Others) 5.2.3. By Therapeutic Area (Oncology, Infectious Disease, Human Genetics/Population Genetics, Others) 5.2.4. By Application (Genomics, Proteomics, Others) 5.2.5. By End Users (Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Other) 5.2.6. By Region 5.2.7. By Company (2025) 5.3. Market Map 6. North America Nucleic Acid Sample Preparation Market Outlook 6.1. Market Size & Forecast 6.1.1. By Value 6.2. Market Share & Forecast 6.2.1. By Product 6.2.2. By Technology 6.2.3. By Therapeutic Area 6.2.4. By Application 6.2.5. By End Users 6.2.6. By Country 6.3. North America: Country Analysis 6.3.1. United States Nucleic Acid Sample Preparation Market Outlook 6.3.1.1. Market Size & Forecast 6.3.1.1.1. By Value 6.3.1.2. Market Share & Forecast 6.3.1.2.1. By Product 6.3.1.2.2. By Technology 6.3.1.2.3. By Therapeutic Area 6.3.1.2.4. By Application 6.3.1.2.5. By End Users 6.3.2. Canada Nucleic Acid Sample Preparation Market Outlook 6.3.2.1. Market Size & Forecast 6.3.2.1.1. By Value 6.3.2.2. Market Share & Forecast 6.3.2.2.1. By Product 6.3.2.2.2. By Technology 6.3.2.2.3. By Therapeutic Area 6.3.2.2.4. By Application 6.3.2.2.5. By End Users 6.3.3. Mexico Nucleic Acid Sample Preparation Market Outlook 6.3.3.1. Market Size & Forecast 6.3.3.1.1. By Value 6.3.3.2. Market Share & Forecast 6.3.3.2.1. By Product 6.3.3.2.2. By Technology 6.3.3.2.3. By Therapeutic Area 6.3.3.2.4. By Application 6.3.3.2.5. By End Users 7. Europe Nucleic Acid Sample Preparation Market Outlook 7.1. Market Size & Forecast 7.1.1. By Value 7.2. Market Share & Forecast 7.2.1. By Product 7.2.2. By Technology 7.2.3. By Therapeutic Area 7.2.4. By Application 7.2.5. By End Users 7.2.6. By Country 7.3. Europe: Country Analysis 7.3.1. Germany Nucleic Acid Sample Preparation Market Outlook 7.3.1.1. Market Size & Forecast 7.3.1.1.1. By Value 7.3.1.2. Market Share & Forecast 7.3.1.2.1. By Product 7.3.1.2.2. By Technology 7.3.1.2.3. By Therapeutic Area 7.3.1.2.4. By Application 7.3.1.2.5. By End Users 7.3.2. France Nucleic Acid Sample Preparation Market Outlook 7.3.2.1. Market Size & Forecast 7.3.2.1.1. By Value 7.3.2.2. Market Share & Forecast 7.3.2.2.1. By Product 7.3.2.2.2. By Technology 7.3.2.2.3. By Therapeutic Area 7.3.2.2.4. By Application 7.3.2.2.5. By End Users 7.3.3. United Kingdom Nucleic Acid Sample Preparation Market Outlook 7.3.3.1. Market Size & Forecast 7.3.3.1.1. By Value 7.3.3.2. Market Share & Forecast 7.3.3.2.1. By Product 7.3.3.2.2. By Technology 7.3.3.2.3. By Therapeutic Area 7.3.3.2.4. By Application 7.3.3.2.5. By End Users 7.3.4. Italy Nucleic Acid Sample Preparation Market Outlook 7.3.4.1. Market Size & Forecast 7.3.4.1.1. By Value 7.3.4.2. Market Share & Forecast 7.3.4.2.1. By Product 7.3.4.2.2. By Technology 7.3.4.2.3. By Therapeutic Area 7.3.4.2.4. By Application 7.3.4.2.5. By End Users 7.3.5. Spain Nucleic Acid Sample Preparation Market Outlook 7.3.5.1. Market Size & Forecast 7.3.5.1.1. By Value 7.3.5.2. Market Share & Forecast 7.3.5.2.1. By Product 7.3.5.2.2. By Technology 7.3.5.2.3. By Therapeutic Area 7.3.5.2.4. By Application 7.3.5.2.5. By End Users 8. Asia Pacific Nucleic Acid Sample Preparation Market Outlook 8.1. Market Size & Forecast 8.1.1. By Value 8.2. Market Share & Forecast 8.2.1. By Product 8.2.2. By Technology 8.2.3. By Therapeutic Area 8.2.4. By Application 8.2.5. By End Users 8.2.6. By Country 8.3. Asia Pacific: Country Analysis 8.3.1. China Nucleic Acid Sample Preparation Market Outlook 8.3.1.1. Market Size & Forecast 8.3.1.1.1. By Value 8.3.1.2. Market Share & Forecast 8.3.1.2.1. By Product 8.3.1.2.2. By Technology 8.3.1.2.3. By Therapeutic Area 8.3.1.2.4. By Application 8.3.1.2.5. By End Users 8.3.2. India Nucleic Acid Sample Preparation Market Outlook 8.3.2.1. Market Size & Forecast 8.3.2.1.1. By Value 8.3.2.2. Market Share & Forecast 8.3.2.2.1. By Product 8.3.2.2.2. By Technology 8.3.2.2.3. By Therapeutic Area 8.3.2.2.4. By Application 8.3.2.2.5. By End Users 8.3.3. Japan Nucleic Acid Sample Preparation Market Outlook 8.3.3.1. Market Size & Forecast 8.3.3.1.1. By Value 8.3.3.2. Market Share & Forecast 8.3.3.2.1. By Product 8.3.3.2.2. By Technology 8.3.3.2.3. By Therapeutic Area 8.3.3.2.4. By Application 8.3.3.2.5. By End Users 8.3.4. South Korea Nucleic Acid Sample Preparation Market Outlook 8.3.4.1. Market Size & Forecast 8.3.4.1.1. By Value 8.3.4.2. Market Share & Forecast 8.3.4.2.1. By Product 8.3.4.2.2. By Technology 8.3.4.2.3. By Therapeutic Area 8.3.4.2.4. By Application 8.3.4.2.5. By End Users 8.3.5. Australia Nucleic Acid Sample Preparation Market Outlook 8.3.5.1. Market Size & Forecast 8.3.5.1.1. By Value 8.3.5.2. Market Share & Forecast 8.3.5.2.1. By Product 8.3.5.2.2. By Technology 8.3.5.2.3. By Therapeutic Area 8.3.5.2.4. By Application 8.3.5.2.5. By End Users 9. Middle East & Africa Nucleic Acid Sample Preparation Market Outlook 9.1. Market Size & Forecast 9.1.1. By Value 9.2. Market Share & Forecast 9.2.1. By Product 9.2.2. By Technology 9.2.3. By Therapeutic Area 9.2.4. By Application 9.2.5. By End Users 9.2.6. By Country 9.3. Middle East & Africa: Country Analysis 9.3.1. Saudi Arabia Nucleic Acid Sample Preparation Market Outlook 9.3.1.1. Market Size & Forecast 9.3.1.1.1. By Value 9.3.1.2. Market Share & Forecast 9.3.1.2.1. By Product 9.3.1.2.2. By Technology 9.3.1.2.3. By Therapeutic Area 9.3.1.2.4. By Application 9.3.1.2.5. By End Users 9.3.2. UAE Nucleic Acid Sample Preparation Market Outlook 9.3.2.1. Market Size & Forecast 9.3.2.1.1. By Value 9.3.2.2. Market Share & Forecast 9.3.2.2.1. By Product 9.3.2.2.2. By Technology 9.3.2.2.3. By Therapeutic Area 9.3.2.2.4. By Application 9.3.2.2.5. By End Users 9.3.3. South Africa Nucleic Acid Sample Preparation Market Outlook 9.3.3.1. Market Size & Forecast 9.3.3.1.1. By Value 9.3.3.2. Market Share & Forecast 9.3.3.2.1. By Product 9.3.3.2.2. By Technology 9.3.3.2.3. By Therapeutic Area 9.3.3.2.4. By Application 9.3.3.2.5. By End Users 10. South America Nucleic Acid Sample Preparation Market Outlook 10.1. Market Size & Forecast 10.1.1. By Value 10.2. Market Share & Forecast 10.2.1. By Product 10.2.2. By Technology 10.2.3. By Therapeutic Area 10.2.4. By Application 10.2.5. By End Users 10.2.6. By Country 10.3. South America: Country Analysis 10.3.1. Brazil Nucleic Acid Sample Preparation Market Outlook 10.3.1.1. Market Size & Forecast 10.3.1.1.1. By Value 10.3.1.2. Market Share & Forecast 10.3.1.2.1. By Product 10.3.1.2.2. By Technology 10.3.1.2.3. By Therapeutic Area 10.3.1.2.4. By Application 10.3.1.2.5. By End Users 10.3.2. Colombia Nucleic Acid Sample Preparation Market Outlook 10.3.2.1. Market Size & Forecast 10.3.2.1.1. By Value 10.3.2.2. Market Share & Forecast 10.3.2.2.1. By Product 10.3.2.2.2. By Technology 10.3.2.2.3. By Therapeutic Area 10.3.2.2.4. By Application 10.3.2.2.5. By End Users 10.3.3. Argentina Nucleic Acid Sample Preparation Market Outlook 10.3.3.1. Market Size & Forecast 10.3.3.1.1. By Value 10.3.3.2. Market Share & Forecast 10.3.3.2.1. By Product 10.3.3.2.2. By Technology 10.3.3.2.3. By Therapeutic Area 10.3.3.2.4. By Application 10.3.3.2.5. By End Users 11. Market Dynamics 11.1. Drivers 11.2. Challenges 12. Market Trends & Developments 12.1. Merger & Acquisition (If Any) 12.2. Product Launches (If Any) 12.3. Recent Developments 13. Global Nucleic Acid Sample Preparation Market: SWOT Analysis 14. Porter's Five Forces Analysis 14.1. Competition in the Industry 14.2. Potential of New Entrants 14.3. Power of Suppliers 14.4. Power of Customers 14.5. Threat of Substitute Products 15. Competitive Landscape 15.1. BGI Group 15.1.1. Business Overview 15.1.2. Products & Services 15.1.3. Recent Developments 15.1.4. Key Personnel 15.1.5. SWOT Analysis 15.2. F. Hoffmann-La Roche Ltd 15.3. Danaher Corporation 15.4. Eppendorf SE 15.5. BIONEER CORPORATION 15.6. Endress+Hauser Group Services AG 15.7. Merck KGaA 15.8. Norgen Biotek Corp. 15.9. Aurora Biomed Inc. 15.10. Agilent Technologies, Inc. 16. Strategic Recommendations 17. About Us & Disclaimer

提及公司

1 BGI Group2 F. Hoffmann-La Roche Ltd3 Danaher Corporation4 Eppendorf SE5 BIONEER CORPORATION6 Endress+Hauser Group Services AG7 Merck KGaA8 Norgen Biotek Corp.9 Aurora Biomed Inc.10 Agilent Technologies, Inc.

同分類最新報告(醫療與生命科學)

常見問題

這份報告可以先索取樣本嗎?

可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算?

報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付?如何付款?

一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。

量子訊息有限公司為 TechSci Research 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們